NDC 17856-2170-01 - Acyclovir suspension
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-2170
- Requested NDC
- 17856-2170-01
- Package NDCs from labels
- 17856-2170-1, 17856-2170-2, 17856-2170-01
- Manufacturer
- Atlantic Biologicals Corp.
- Effective date
- 2026-05-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Acyclovir Oral Suspension, USP | Atlantic Biologicals Corp. | 2026-05-04 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-2170-1 | Acyclovir suspension | 72 in 1 CASE | SUSPENSION | 72 | 1 | |
| 17856-2170-1 | Acyclovir suspension | 5 mL in 1 CUP, UNIT-DOSE | SUSPENSION | 5 | 1 | |
| 17856-2170-2 | Acyclovir suspension | 10 mL in 1 CUP, UNIT-DOSE | SUSPENSION | 10 | 1 | |
| 17856-2170-2 | Acyclovir suspension | 72 in 1 CASE | SUSPENSION | 72 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Walgreens Hemorrhoidal Pain Relief | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Walgreens | e79ed7ae-0d06-2f88-e053-2995a90a1e35 | 2024-09-20 | Warnings | PDC6A3C0OX |
| Soothe | GLYCERIN AND PROPYLENE GLYCOL | Bausch & Lomb Incorporated | fef002ea-c4bd-4486-a42e-1bbd9d73d28d | 2024-09-20 | Warnings | PDC6A3C0OX |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | e0f17e6f-63c7-4828-8585-91fc582df30b | 2024-09-06 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | f09cdb3f-dfd2-4e47-bb5e-a5d26d8bcc89 | 2024-09-06 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | 8c5d1f30-2d31-417d-860b-7228b7baaa64 | 2024-09-06 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Golden State Medical Supply, Inc. | 785d68bc-0bbf-b69d-e053-2991aa0ac0d5 | 2024-09-05 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | af9d41f5-4658-4487-8811-32a1f8af9384 | 2024-09-05 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | 89583890-186b-4a7a-8741-41f6c5f0a99d | 2024-09-05 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | 01ae85df-d1a0-44f7-b4c0-0ac74d2216d4 | 2024-09-05 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Carlsbad Technology, Inc. | a68e610a-841c-4b69-9233-673d060561e8 | 2024-08-26 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Carlsbad Technology, Inc. | 37499620-6a17-40f1-b0db-dd79320ea21d | 2024-08-26 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | c46d5033-b1b2-e213-e053-2995a90ae6a3 | 2024-08-22 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | NuCare Pharmaceuticals, Inc. | 40e5cc54-ed74-3369-e054-00144ff88e88 | 2024-08-14 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Zydus Lifesciences Limited | bb956f2b-627a-49bd-b258-4aac21d64b9a | 2024-08-14 | X4HES1O11F | |
| acyclovir | ACYCLOVIR | Zydus Lifesciences Limited | fdf6b492-a76e-4cea-89a1-a5b19c7938ff | 2024-08-14 | X4HES1O11F | |
| Empathy | AETHUSA CYNAPIUM, AMBRA GRISEA, ARGEMONE MEXICANA, CANDIDA ALBICANS, CARLSBAD AQUA, CEREBRUM SUIS, COCCULUS INDICUS, COFFEA TOSTA, CROCUS SATIVUS, CYCLAMEN EUROPAEUM, MAGNESIA CARBONICA, NATRUM CARBONICUM, NUPHAR LUTEUM, NUX MOSCHATA, PHOSPHORUS, PLACENTA TOTALIS SUIS, ROSA DAMASCENA, SUCCINUM, VIOLA ODORATA | Deseret Biologicals, Inc. | a89067c1-ef12-49da-8fa6-e65ff664f497 | 2024-08-13 | Warnings | 059QF0KO0R |
| acyclovir | ACYCLOVIR | Bryant Ranch Prepack | a7fd298b-3914-4316-8484-2d3ae188221a | 2024-08-12 | Warnings, Adverse reactions | X4HES1O11F |
| Up and Up Hemorrhoid MAX STRENGTH | 14.4% GLYCERIN, 0.25% PHENYLEPHRINE HCL, 1% PRAMOXINE HCL, 15% PETROLATUM | Target Corporation | 867677b5-fd1d-449e-966e-1de0b5c98afb | 2024-08-08 | Warnings | PDC6A3C0OX |
| acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | ada4004a-c10a-6190-e053-2a95a90a5e67 | 2024-07-17 | Warnings, Adverse reactions | X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | b1b999a9-11cc-d6e5-e053-2995a90a5478 | 2024-07-17 | Warnings, Adverse reactions | X4HES1O11F |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.